Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 22:09:23 GMT 2025
by
admin
on
Mon Mar 31 22:09:23 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IMMUNOMODULATOR |
| Sequence Origin | HUMANIZED |
| Sequence Type | COMPLETE |
| Record UNII |
LCT264LTYE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Lulizumab pegol
Created by
admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
|
PRIMARY | |||
|
DB15441
Created by
admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
|
PRIMARY | |||
|
SUB179558
Created by
admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
|
PRIMARY | |||
|
100000164922
Created by
admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
|
PRIMARY | |||
|
LCT264LTYE
Created by
admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
|
PRIMARY | |||
|
1421830-13-8
Created by
admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
|
PRIMARY | |||
|
9940
Created by
admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
|
PRIMARY | |||
|
C175727
Created by
admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
|
PRIMARY | |||
|
AB-119
Created by
admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
|
PRIMARY | |||
|
CHEMBL3137354
Created by
admin on Mon Mar 31 22:09:23 GMT 2025 , Edited by admin on Mon Mar 31 22:09:23 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_23 | 1_88 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | [1_70] | Cys | CYSTEINE, LULIZUMAB PEGOL- | 19B9R7LQ7A |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|